A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(83 sites)

United States

SEC Clinical Research LLC, Andalusia, Alabama

UAB St Vincents, Birmingham, Alabama

Longwood Research, Huntsville, Alabama

The Center for Clinical Trials, Saraland, Alabama

Elite Clinical Studies, Phoenix, Arizona